Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL

Blood. 2020 May 28;135(22):2000-2004. doi: 10.1182/blood.2019003539.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Autografts
  • Clonal Evolution / drug effects
  • Clonal Evolution / genetics
  • Clonal Hematopoiesis / drug effects*
  • Clonal Hematopoiesis / genetics
  • Cohort Studies
  • DNA Repair / genetics
  • Female
  • Humans
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / genetics
  • Lymphoma, Mantle-Cell / pathology*
  • Male
  • Middle Aged
  • Mutation
  • Neoplasm, Residual / drug therapy
  • Neoplasm, Residual / genetics
  • Neoplasm, Residual / pathology
  • Stem Cell Transplantation

Substances

  • Antineoplastic Agents